SCHEMBL7988934

SCHEMBL7988934

Cc1cccc(Cn2cnc3nc(-c4cccnc4)nc(O)c32)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.47
CYP3A4 P08684 4/20 0.47
CYP2D6 P10635 4/20 0.47
CYP2C19 P33261 4/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
TSHR P16473 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
HPGD P15428 2/20 0.47
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 2/20 0.44
KDM4E B2RXH2 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
CYP11B1 P15538 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988747 0.89 CYP11B1 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7984769 0.89 CLK4 (0.44) ALDH1A1HSD17B10SMN1; SMN2MAPTKMT2A
SCHEMBL7974268 0.88 CYP11B1 (0.48) ALDH1A1TSHRHPGDSMN1; SMN2MAPT
SCHEMBL7985334 0.88 ABCG2 (0.46) ALDH1A1KDM4ECYP11B1CYP11B2GRIN1
SCHEMBL7988659 0.88 P2RX7 (0.41) CYP3A4CYP2D6CYP2C19SMN1; SMN2MAPT
SCHEMBL7987433 0.87 ROCK2 (0.54) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7974286 0.87 DHPS (0.49) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7974247 0.86 CYP11B1 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7991557 0.85 LMNA (0.43) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7988958 0.84 ALDH1A1 (0.42) ALDH1A1TSHRHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed